---
category: news
title: "Neoleukin Therapeutics: De Novo Protein Design Platform"
excerpt: "Neoleukin is a leader in de novo drug design. The company's lead asset was recently put on clinical hold, pending more dosing data, creating a window to buy the stock."
publishedDateTime: 2021-02-03T17:16:00Z
originalUrl: "https://seekingalpha.com/article/4403044-neoleukin-therapeutics-de-novo-protein-design-platform"
webUrl: "https://seekingalpha.com/article/4403044-neoleukin-therapeutics-de-novo-protein-design-platform"
type: article
quality: 24
heat: 24
published: false

provider:
  name: Seeking Alpha
  domain: seekingalpha.com

topics:
  - Google AI
  - AI

images:
  - url: "https://static.seekingalpha.com/uploads/2021/2/2/saupload_xKHvUCjiNtdzHZnqgZvCdxEVRlFJlcA-U1bnsI2tlJiTUgKQTfESbMZL0m9oyRjVVZm1Q_r3z2ayp0ZCuku-Z2JtKXsdrlmyDoVOgpwh4Qy4EeTpUhD9p6zDfeDDi4e8yL2nu2x6.png"
    width: 1016
    height: 505
    isCached: true

secured: "pC5UzSVxNFZ8r3eEh3GyL5HS0dLZsT/9j3lnmX0KDrZwyZw/GPdbP0Tifzp0nMi0nDYCcfqrDvMhhm7ZjUosFMEfvLunA4KPOhztBIC277WcyJPVreFIqK+7FgrmLH6BHGMVP3PFaBeiJyfwAK3K4tkCMGFBdUqO8SwFqhuL3zm5BQn6wiWqMnNnDX2aYTqTzJOQ7e6C0HB4bKhBoi1pe4uN8ReGLDXxlfuOEmCxEPUN9+vRm+EoubYmqg0HEyEyNdGz4MQhKUx9ztNNKEguj+LyK+23uNXAkaR5z20vfrQVxZ7hfXqg8SEzWL4OoJ51L8xoNmRjW0xaZZf0QUh58DxLD3OTkXJQW68mPyOwzMU=;Z17OjJEnKyENbFDBf7+xqw=="
---

